IASLC-TTLC 2021 - IASLC 2021 Targeted Therapies of Lung Cancer (Virtual Meeting)
Feb 17 - Mar 04, 2021 | Santa MonicaCAUS
LARVOL is not affiliated with IASLC 2021 Targeted Therapies of Lung Cancer (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 4 abstracts linked to Trials
[VIRTUAL] The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC
[VIRTUAL] Neratinib Efficacy in Patients with EGFR Exon 18-Mutant Non-Small Cell Lung Cancer (NSCLC): Findings from the SUMMIT Basket Trial
[VIRTUAL] Precision Targeted Therapy for RET-driven NSCLC and Emerging Evidence of Acquired Resistance to RET-Specific Tyrosine Kinase Inhibitors
[VIRTUAL] Detection of DNA Replication Blocker SLFN11 in Tumor Tissue and Circulating Tumor Cells to Predict Platinum Response in Small Cell Lung Cancer